Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

      Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

      Medical Dialogues Bureau14 April 2020 3:16 PM IST
      Delhi: Indian Pharma industry is producing enough stocks of essential medicines particularly HCQ to meet both domestic demands and to meet export...
      Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

      Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

      Medical Dialogues Bureau14 April 2020 2:52 PM IST
      The raw materials which earlier used to cost Rs 9,000 per kilogram are now being sold at Rs 55,000-75,000
      Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

      Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

      Medical Dialogues Bureau14 April 2020 1:45 PM IST
      Mumbai: The Joint Managing Director of Ipca Laboratories Ajit Kumar Jain on Saturday said that hydroxychloroquine is not approved as an anti-malarial...
      Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

      Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

      Medical Dialogues Bureau14 April 2020 1:41 PM IST
      "The funding will allow us to invest further into improving patient outcomes and generate further real-world evidence while expanding our therapeutic...
      Top priority on Delivery of Medicines through Speed Post: Minister

      Top priority on Delivery of Medicines through Speed Post: Minister

      Medical Dialogues Bureau14 April 2020 1:40 PM IST
      Delhi: With the rising cases of coronavirus and the consequent lockdown preventing the movement of people even to take their essential...
      Lasa Supergenerics gets FDA nod for Progesterone

      Lasa Supergenerics gets FDA nod for Progesterone

      Medical Dialogues Bureau14 April 2020 9:00 AM IST
      Mumbai: API producer, Lasa Supergenerics Ltd has forayed into the hormone and steroid API segment for Human application with its approval from the...
      Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

      Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

      Medical Dialogues Bureau13 April 2020 3:48 PM IST
      Companies like Zydus Cadila and IPCA are the major manufacturers of hydroxychloroquine in the country, Jain said
      SMS Pharma updates against USFDA statement on Ranitidine

      SMS Pharma updates against USFDA statement on Ranitidine

      Medical Dialogues Bureau13 April 2020 2:31 PM IST
      India: Through a recent release with the exchanges, SMS Pharma has provided update against USFDA statement on RanitidineSMS Pharma is one of the...
      Lupin Contributes Rs 21 crores in battle against COVID-19

      Lupin Contributes Rs 21 crores in battle against COVID-19

      Medical Dialogues Bureau13 April 2020 1:00 PM IST
      Mumbai: Lupin Limited has announced a contribution of INR 21 crores for relief efforts directed towards mitigating the COVID-19 crisis. Lupin's...
      AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

      AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

      Medical Dialogues Bureau13 April 2020 12:32 PM IST
      Kenilworth: AstraZeneca and MSD Inc. has announced that the US Food and Drug Administration (FDA) has approved the kinase inhibitor Koselugo...
      Lupin gets USFDA EIR for Nagpur Facility

      Lupin gets USFDA EIR for Nagpur Facility

      Medical Dialogues Bureau13 April 2020 11:02 AM IST
      Mumbai: Lupin Limited has announced the receipt of the Establishment Inspection Report (EIR) after the closure of the U.S. FDA inspection of its...
      KKRs Envision Healthcare hires bank to explore debt restructuring: Report

      KKR's Envision Healthcare hires bank to explore debt restructuring: Report

      Medical Dialogues Bureau13 April 2020 9:00 AM IST
      US: Envision Healthcare Corp, a U.S. provider of physicians and other medical staff owned by buyout firm KKR & Co Inc (KKR.N), has hired a...
      Next

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok